NEW YORK (Reuters Health) - For patients with type 2 diabetes not controlled with metformin and a sulfonylurea, the choice of an additional agent should be based on individual clinical characteristics since improvements in glucose control are similar.

Get the latest industry news, event updates, and more from Managed healthcare Executive.

Subscribe Now!

Third agents for type 2 diabetes are similar in efficacy

Newsletter